Market Research Report
EUROPE BETA GLUCAN MARKET FORECAST 2018-2026
|Published by||Inkwood Research||Product code||636635|
|Published||Content info||98 Pages
Delivery time: 1-2 business days
|EUROPE BETA GLUCAN MARKET FORECAST 2018-2026|
|Published: May 14, 2018||Content info: 98 Pages||
Europe beta glucan market has its primary application in food & beverages sector, pharmaceutical sector, animal feed and the personal care sector. As a result, the market is expected to rise with a CAGR of 7.29% over the forecast period of 2018-2026. European markets like UK, Germany, Spain, Italy, France and rest of Europe are covered in this report.
High demand for packaged foods and increasing prevalence of packaged foods are driving the beta-glucan market demand in the UK. The France beta glucan market is expanding due to increasing demand from the pharmaceutical sector while the German market is being propelled by its cosmetics and personal care sector. The growing prevalence of Cancer in the overall European market too is acting as a critical factor in enhancing the market demand. According to European Commission, Cancer has become the leading cause of death in European Union over the last decade (2007-2017). Beta-glucans can be used intravenously to treat various forms of cancers and boost the immune system of individuals.
Major market players like Specialty Biotech Ltd, Lesaffre Human Care, Cargill Inc, Alltech Biotechnology, Pharmacon Asa, Ohly, Kemin Industries, Kerry Group Plc, Super Beta Glucan, Milliporesigma (Merck) and Tate & Lyle Plc are competing in this market.